FOLH1 and prostate carcinoma: In addition, Rhee et al. and Berger et al. conducted their studies when the use of PSMA PET/CT in the diagnosis of prostate cancer was relatively new and lacked the reporting guidelines to make accurate diagnoses [14,22].